Search - tctmd.com

Displaying 341 - 360 of 1423

Sort: Relevancy | Date

Presentation TCT 2017

CLI and Lower Extremity Intervention: Devices and Techniques for Complex Disease in the Office Interventional Suites

Presenter: Brian G. DeRubertis, Bret N. Wiechmann

October 31, 2017

Presentation TCT 2017

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen

October 31, 2017

Presentation TCT 2017

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Gregg W. Stone

October 31, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day Two

Shelley Wood

October 31, 2017

Presentation TCT 2017

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Stephen G. Ellis

October 31, 2017

Presentation TCT 2017

Editorial Perspective: Clinical Outcomes and Interventional Options in CLI Patients

Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, Mahmood K. Razavi

October 31, 2017

Presentation TCT 2017

Interventional Blood Flow Reversal Therapy for the Non-option CLI Patient (LimFlow)

Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, Daniel Rose

October 31, 2017

Presentation TCT 2017

Editorial Perspective: Vascular Access Complications in the TAVR Area: Frequency and Clinical Outcomes

Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, Susheel K. Kodali

October 31, 2017

Presentation TCT 2017

Impact of Treatment Location on Clinical Outcomes of Office-Based Endovascular Procedures

Presenter: Jeffrey G. Carr, Schuyler Jones

October 31, 2017

Presentation TCT 2017

Pedal Interventions in Complex CLI Patients

Presenter: Mahmood K. Razavi, Peter A. Schneider, Arthur C. Lee

October 31, 2017

Presentation TCT 2017

Featured Lecture: The NIH Mission to Enhance DIVERSITY in Clinical Trials, Education, and the Workforce

Presenter: Roxana Mehran, George A. Mensah

October 31, 2017

Presentation TCT 2017

Intelligence for Better Clinical Care (Imperative)

Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, Gopal Chopra

October 31, 2017

News Opinion Off Script TCT 2017

Off Script: Monkey See, Monkey . . . Should Really Do, Before Being Set Loose

Kwan S. Lee

October 30, 2017

Presentation TCT 2017

When is TAVR Indicated for Low Gradient AS With Preserved Ejection Fraction? Case Examples

Presenter: Mackram F. Eleid

October 30, 2017

Presentation TCT 2017

Clinical Management of Low Flow-Low Gradient AS: The Role of TAVR

Presenter: Howard C. Herrmann

October 30, 2017

Presentation TCT 2017

Pacemaker Mediated Hypertension Treatment (BackBeat): First-in-Man Results and Ongoing Plans

Presenter: Elazer R. Edelman, Paul A. Sobotka, Karl-Heinz Kuck

October 30, 2017

Presentation TCT 2017

Harpoon for Degenerative MR: Device, Clinical Studies Update, and Future Directions

Presenter: James B. Hermiller Jr., Ralph Stephan von Bardeleben, James S. Gammie

October 30, 2017

Presentation TCT 2017

Classifying Aortic Stenosis According to Pathophysiology and Hemodynamics An Echocardiographers Perspective

Presenter: Philippe Pibarot

October 30, 2017

Presentation TCT 2017

AV-Fistula Creation (ROX Coupler): Extended Follow-up Results and Next Steps

Presenter: Elazer R. Edelman, Paul A. Sobotka, Krishna J. Rocha-Singh

October 30, 2017

Presentation TCT 2017

How to Optimally Perform Valve-in-Valve Implantation in a Small Surgical Valve (Including Bioprosthetic Valve Fracture) Case Examples

Presenter: Danny Dvir

October 30, 2017

Advertisement

CLI and Lower Extremity Intervention: Devices and Techniques for Complex Disease in the Office Interventional Suites

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Live From Denver: TCT 2017, Day Two

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Editorial Perspective: Clinical Outcomes and Interventional Options in CLI Patients

Interventional Blood Flow Reversal Therapy for the Non-option CLI Patient (LimFlow)

Editorial Perspective: Vascular Access Complications in the TAVR Area: Frequency and Clinical Outcomes

Impact of Treatment Location on Clinical Outcomes of Office-Based Endovascular Procedures

Pedal Interventions in Complex CLI Patients

Featured Lecture: The NIH Mission to Enhance DIVERSITY in Clinical Trials, Education, and the Workforce

Intelligence for Better Clinical Care (Imperative)

Off Script: Monkey See, Monkey . . . Should Really Do, Before Being Set Loose

When is TAVR Indicated for Low Gradient AS With Preserved Ejection Fraction? Case Examples

Clinical Management of Low Flow-Low Gradient AS: The Role of TAVR

Pacemaker Mediated Hypertension Treatment (BackBeat): First-in-Man Results and Ongoing Plans

Harpoon for Degenerative MR: Device, Clinical Studies Update, and Future Directions

Classifying Aortic Stenosis According to Pathophysiology and Hemodynamics An Echocardiographers Perspective

AV-Fistula Creation (ROX Coupler): Extended Follow-up Results and Next Steps

How to Optimally Perform Valve-in-Valve Implantation in a Small Surgical Valve (Including Bioprosthetic Valve Fracture) Case Examples

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content